These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17116129

  • 1. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
    Bishton MJ, Haynes AP.
    Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
    [Abstract] [Full Text] [Related]

  • 2. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
    Clavio M, Garrone A, Pierri I, Michelis GL, Balocco M, Albarello A, Varaldo R, Canepa P, Miglino M, Ballerini F, Canepa L, Gobbi M.
    Oncol Rep; 2005 Oct; 14(4):933-40. PubMed ID: 16142354
    [Abstract] [Full Text] [Related]

  • 3. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 4. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH, Chen YA, Corringham S, Bashey A, Holman P, Ball ED, Carrier E.
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [Abstract] [Full Text] [Related]

  • 5. Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
    Fetscher S, Lübbert M, Kanz L, Behringer D, Finke J, Mertelsmann R, Lange W.
    Bone Marrow Transplant; 1997 Mar; 19(5):527-8. PubMed ID: 9052926
    [Abstract] [Full Text] [Related]

  • 6. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R, Conde E, Grande C, Mateos MV, Gandarillas M, Albo C, Lahuerta JJ, Fernández-Rañada JM, Hernández MT, Alonso N, García Vela JA, Garzón S, Rodríguez J, Caballero D, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL-TAMO).
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [Abstract] [Full Text] [Related]

  • 7. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM.
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [Abstract] [Full Text] [Related]

  • 8. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P, Lemevel A, Bertrand P, Delwail V, Rachieru P, Brion A, Berthou C, Bay JO, Delepine R, Desablens B, Camilleri-Broët S, Linassier C, Lamy T.
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [Abstract] [Full Text] [Related]

  • 9. Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma.
    Al-Toma A, Verbeek WH, Visser OJ, Kuijpers KC, Oudejans JJ, Kluin-Nelemans HC, Mulder CJ, Huijgens PC.
    Dig Liver Dis; 2007 Jul; 39(7):634-41. PubMed ID: 17531561
    [Abstract] [Full Text] [Related]

  • 10. Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.
    Au WY, Lie AK, Siu LL, Chan EC, Ooi GC, Leung AY, Liang R, Kwong YL.
    Ann Hematol; 2003 Sep; 82(9):548-51. PubMed ID: 14504811
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
    Margolin KA, Doroshow JH, Frankel P, Chow W, Leong LA, Lim D, McNamara M, Morgan RJ, Shibata S, Somlo G, Twardowski P, Yen Y, Kogut N, Schriber J, Alvarnas J, Stalter S.
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):903-11. PubMed ID: 16275593
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ.
    Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
    Schlemmer M, Wendtner CM, Falk M, Abdel-Rahman S, Licht T, Baumert J, Straka C, Hentrich M, Salat C, Hiddemann W, Issels RD.
    Oncology; 2006 Mar; 71(1-2):32-9. PubMed ID: 17344669
    [Abstract] [Full Text] [Related]

  • 14. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG, Haynes AP, Iqbal A, Russell NH.
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract] [Full Text] [Related]

  • 15. [Autologous transplant with BEAM protocol in lymphoma].
    Caballero D, Rubio V, Rifon J, Heras I, García-Sanz R, Vidriales B, Pérez-Simón JA, del Cañizo C, González M, León A, Jean-Paul E, Rocha E, Vicente V, San Miguel JF.
    Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
    [No Abstract] [Full Text] [Related]

  • 16. High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.
    Torjman L, Ladeb S, Lakhal A, Ben Othman T, Abdelkefi A, Ben Abdeladhim A.
    Tunis Med; 2007 Jan; 85(1):35-8. PubMed ID: 17424707
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).
    Glossmann JP, Josting A, Pfistner B, Paulus U, Engert A, German Hodgkin's Lymphoma Study Group (GHSG).
    Ann Hematol; 2002 Aug; 81(8):424-9. PubMed ID: 12223998
    [No Abstract] [Full Text] [Related]

  • 18. Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?
    Al-Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A.
    Pediatr Blood Cancer; 2007 Aug; 49(2):190-5. PubMed ID: 17262797
    [Abstract] [Full Text] [Related]

  • 19. Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
    Eckrich MJ, Domm J, Ho R, Whitlock JA, Frangoul H.
    Pediatr Blood Cancer; 2009 Dec 15; 53(7):1327-8. PubMed ID: 19760777
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation.
    Sieniawski M, Angamuthu N, Boyd K, Chasty R, Davies J, Forsyth P, Jack F, Lyons S, Mounter P, Revell P, Proctor SJ, Lennard AL.
    Blood; 2010 May 06; 115(18):3664-70. PubMed ID: 20197551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.